Apogee Therapeutics, Inc. (APGE)
86.26
+3.54
(+4.28%)
USD |
NASDAQ |
Jun 11, 13:36
Apogee Therapeutics Market Cap : 6.459B for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 6.194B |
| June 09, 2026 | 6.365B |
| June 08, 2026 | 6.216B |
| June 05, 2026 | 6.509B |
| June 04, 2026 | 6.807B |
| June 03, 2026 | 6.304B |
| June 02, 2026 | 5.894B |
| June 01, 2026 | 5.938B |
| May 29, 2026 | 6.151B |
| May 28, 2026 | 5.827B |
| May 27, 2026 | 5.862B |
| May 26, 2026 | 6.243B |
| May 22, 2026 | 6.119B |
| May 21, 2026 | 6.214B |
| May 20, 2026 | 6.136B |
| May 19, 2026 | 5.901B |
| May 18, 2026 | 5.937B |
| May 15, 2026 | 6.117B |
| May 14, 2026 | 6.326B |
| May 13, 2026 | 6.328B |
| May 12, 2026 | 6.252B |
| May 11, 2026 | 6.378B |
| May 08, 2026 | 6.260B |
| May 07, 2026 | 6.168B |
| May 06, 2026 | 6.373B |
| Date | Value |
|---|---|
| May 05, 2026 | 5.734B |
| May 04, 2026 | 5.752B |
| May 01, 2026 | 5.559B |
| April 30, 2026 | 5.707B |
| April 29, 2026 | 5.648B |
| April 28, 2026 | 5.878B |
| April 27, 2026 | 5.953B |
| April 24, 2026 | 5.894B |
| April 23, 2026 | 6.079B |
| April 22, 2026 | 6.243B |
| April 21, 2026 | 6.256B |
| April 20, 2026 | 6.260B |
| April 17, 2026 | 6.348B |
| April 16, 2026 | 6.234B |
| April 15, 2026 | 6.149B |
| April 14, 2026 | 6.091B |
| April 13, 2026 | 5.972B |
| April 10, 2026 | 5.939B |
| April 09, 2026 | 5.957B |
| April 08, 2026 | 5.723B |
| April 07, 2026 | 5.734B |
| April 06, 2026 | 5.784B |
| April 02, 2026 | 5.807B |
| April 01, 2026 | 5.800B |
| March 31, 2026 | 5.795B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evommune, Inc. | 747.02M |
| Cogent Biosciences, Inc. | 5.543B |
| Kymera Therapeutics, Inc. | 6.787B |
| Erasca, Inc. | 4.267B |
| GRAIL, Inc. | 2.493B |
Market Cap Related Metrics
| PEG Ratio | -0.8991 |
| Price to Book Value | 5.144 |
| Price | 86.26 |
| Earnings Yield | -5.02% |
| PEGY Ratio | -0.8991 |